Chromogranin A (CgA) in the Diagnosis and Monitoring of Patients with Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NET): A Single-Institution Experience

被引：0
|
作者：
Massironi, S. [1 ]
Rossi, R. E.
Spampatti, M. P.
Casazza, G. [2 ]
Conte, D.
Ciafardini, C.
Cavalcoli, F.
Peracchi, M.
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[2] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
cga; gep-net;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] Chromogranin A (CgA) serum levels correlate with hepatic tumor burden in patients with neuroendocrine gastroenteropancreatic (GEP) tumors
    Rinke, A
    Wilke, A
    Mayer, C
    Scherag, A
    Klose, KJ
    Arnold, R
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 45 - 45
  • [2] The diagnosis and medical management of gastroenteropancreatic neuroendocrine tumors (GEP NET)
    Kos-Kudla, Beata
    Foltyn, Wanda
    Zemczak, Anna
    Marek, Bogdan
    Sieminska, Lucyna
    Kajdaniuk, Dariusz
    PRZEGLAD GASTROENTEROLOGICZNY, 2006, 1 (01): : 3 - 9
  • [3] Gastroenteropancreatic Neuroendocrine Tumors: Single-Institution Clinicopathological Study
    Vaslamatzis, M.
    Papaxoinis, G.
    Tsiga, A.
    Mantzaris, G.
    Exarchos, D.
    Alfaras, P.
    Delaki, C.
    Alevizopoulos, N.
    Patila, E.
    Zoublios, C.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 64 - 64
  • [4] Polish recommendation for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors (GEP NET)
    Kos-Kudla, Beaty
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (02): : 73 - 78
  • [5] Pathology classification of gastroenteropancreatic (GEP) neuroendocrine tumors (NET)
    Rindi, Guido
    ENDOCRINE JOURNAL, 2010, 57 : S279 - S279
  • [6] Chromogranin A in Diagnosing and Monitoring Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Large Series from a Single Institution
    Massironi, Sara
    Rossi, Roberta Elisa
    Casazza, Giovanni
    Conte, Dario
    Ciafardini, Clorinda
    Galeazzi, Marianna
    Peracchi, Maddalena
    NEUROENDOCRINOLOGY, 2014, 100 (2-3) : 240 - 249
  • [7] The Clinical Impact of Serum Chromogranin-A in Patients With Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Wu, S.
    Reta-Impey, P.
    Manivannan, N.
    Fu, P.
    Cao, S.
    Asa, S.
    Tirumani, S. H.
    Davidson, J.
    Kardan, A.
    Avril, N.
    Wojtylak, P.
    Bajor, D.
    Lee, R.
    Selfridge, E.
    Saltzman, J.
    Ammori, J.
    Hardacre, J.
    Winter, J.
    Mohamed, A.
    PANCREAS, 2021, 50 (03) : 450 - 450
  • [8] Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET)
    Goretzki, P. E.
    Starke, A.
    Akca, A.
    Lammers, B. J.
    INTERNIST, 2012, 53 (02): : 152 - 160
  • [9] Clinicopathological Features and Prognosis of Gastroenteropancreatic Neuroendocrine Tumors: Analysis from a Single-institution
    Zeng, Yu-Jie
    Liu, Lu
    Wu, Heng
    Lai, Wei
    Cao, Jie-Zhi
    Xu, He-Yang
    Wang, Jie
    Chu, Zhong-Hua
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 5775 - 5781
  • [10] Baseline and dynamic plasma chromogranin A (CgA) level to predict clinical outcome and tumor response in Asian patients with gastroenteropancreatic neuroendocrine tumor (GEP-NET).
    Chou, Wen-Chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345